Merck KGaA acquires SpringWorks Therapeutics, Inc. for $3.9B, boosting its pipeline with OGSIVEO & GOMEKLI. Click for more on ...

Merck is investing $1 billion to build a U.S. plant in Delaware, in a show of its commitment to domestic manufacturing.

The global quinoline market is estimated to reach USD 379.5 million in 2025, with a projected valuation of USD 538.6 million by 2035. Pharmaceuticals remain the largest application segment, driven by ...